Key Takeaways
- •A claim is not evidence, and a chain is not a claim. Lot number to sample ID to named laboratory to stated method to reported result to your own receiving record. Break any join and the number stops being traceable to the vial in your hand.
- •Purity is a ratio and content is an amount. A vial can read 99.2% by HPLC and still hold 7.8 mg of peptide against a 10 mg label, because water and counterion are part of the powder but not part of the purity figure.
- •That gap propagates into every downstream number. Assume the label and every concentration you calculate from it is roughly 28% high, in the worked example below, before the experiment even starts.
- •A mass is not an identity. Matching molecular weight is consistent with the labelled sequence and with every rearrangement of the same residues. Identity is a separate experiment, and it is rarely on the certificate.
- •Health Canada's published position is explicit. Its 9 April 2026 advisory states that in Canada "peptides are generally regulated as prescription drugs," and that research-use-only labelling "does not make these products legal or exempt from regulatory requirements."
- •Ten minutes of document checking removes most bad suppliers. Ask for the certificate covering the exact lot currently shipping, before you pay. A supplier who cannot produce one has answered the question.
Three claims sit on almost every peptide sold into Canada: high purity, third-party tested, ships domestically. All three are checkable. Almost nobody checks them, because checking means knowing which document answers which question, and most product pages are arranged so that one document appears to answer all of them at once.
It does not. A purity percentage, an identity result and a fill quantity are three separate experiments, run on different instruments, reported in different units. A certificate that reports one of them and implies the other two is not dishonest so much as incomplete, and the incompleteness is invisible unless you know what the missing fields were called.
This guide treats the vial as the end of a chain rather than as a product. The chain starts at a synthesis lot and ends at the note you write when the parcel arrives, and it is only as strong as the weakest join in it. What follows is where each join sits, what proves it, and the specific way each one fails in this market. It is written for laboratory and in-vitro work. There is no administration guidance anywhere in it, and none should be inferred.
The Five Questions a Vial Has to Answer
Before any of the documentation makes sense, it helps to separate the questions it might be answering. They are genuinely distinct, and a strong answer to one implies nothing whatsoever about the others.
| Question | Plain form | What answers it | Units |
|---|---|---|---|
| Identity | Is this the sequence on the label? | MS for mass, MS/MS or Edman for order, co-elution against a reference standard | A match, or not |
| Purity | How much of what the detector sees is the main component? | RP-HPLC area percent at a stated wavelength | Percent of chromatographic area |
| Content | How much peptide is actually in the vial? | Assay against a standard, plus water and counterion determination | Milligrams |
| Provenance | Does this paperwork describe this vial? | Lot number, sample ID, report number, analysis date | Identifiers that agree |
| Handling | Has it been kept in a state where the answers still hold? | Storage conditions, transit temperature, freeze-thaw history | Your own log |
Most certificates in this market answer the second question well, gesture at the third, treat the first as a corollary of a matching mass, and leave the last two entirely to the buyer. The first four are the supplier's to answer. The fifth is always yours, and no vendor can supply it for you.
The Chain, Link by Link
Verification is not a single check. It is six joins, each of which has to hold for the certificate to describe the material you were sent.
| Link | The artefact | What proves it | How it breaks in practice |
|---|---|---|---|
| 1. Synthesis lot | A lot or batch number printed on the vial label | The same string appears on the certificate | The vial carries no lot at all, or carries one that appears on no document |
| 2. Sample submitted | A sample or submission ID on the report | Sample ID and lot number appear on the same page | The report names a sample that cannot be tied back to any batch |
| 3. Laboratory | A named laboratory, a report number, and ideally a lookup key | The report number resolves on the laboratory's own site, not the vendor's | The lab is unnamed, or named with no independent way to confirm the report exists |
| 4. Method | Column, gradient, wavelength, instrument, and what was injected | The parameters are printed, not summarised as "HPLC" | A percentage on a cover page with no method behind it |
| 5. Result | A chromatogram, a peak table, and a measured quantity | Peaks are visible and integrate to the stated figure | A single large number, no trace, no integration table |
| 6. Receipt | Your own record: arrival date, condition, storage, lot | You wrote it down on the day | Nothing was recorded, and six months later the result cannot be attributed |
Links one through five are what a supplier owes you. Link six costs nothing and is the one most often missing, which is a strange thing to be true of the free one.
Why the joins matter more than the values
A certificate reporting 99.4% from a named laboratory, on a lot number that matches the vial, with the chromatogram attached, is a strong document at 99.4%. The same certificate with the lot number removed is a weak document at 99.9%. The number is the least load-bearing part of the page. It is the identifiers around it that decide whether the number is about your material.
Purity Is a Ratio, Content Is an Amount
This is the single most expensive misreading in the market, and it survives because both figures are reported as percentages of something.
A lyophilised research peptide is not pure peptide powder. It is peptide, plus residual water absorbed during and after freeze-drying, plus the counterion left over from purification, usually trifluoroacetate from the reversed-phase step or acetate if the material was ion-exchanged afterwards. All three are in the vial. Only the first is what you are trying to buy.
Work it through on a vial labelled 10 mg:
| Component | Typical share of lyophilate | Mass in a 10 mg vial |
|---|---|---|
| Peptide | 78% | 7.8 mg |
| Counterion (TFA or acetate) | 14% | 1.4 mg |
| Residual water | 8% | 0.8 mg |
| Total powder | 100% | 10.0 mg |
Now run the HPLC. The chromatogram sees peptide-related species that absorb at the detection wavelength. Water does not absorb there. The counterion does not appear as a peak. So the trace can return 99.2% purity on material that is 78% peptide by mass, and both figures are correct, because they are measuring different things.
The counterion share is not a rounding error either. It scales with the number of basic residues in the sequence, so a lysine-rich or arginine-rich peptide carries proportionally more salt than a neutral one. Two vials of two different compounds, both honestly labelled 10 mg, both 99% pure, can differ by several milligrams of actual peptide.
The error does not stay put
Suppose you dissolve that vial in 2 mL and calculate a stock concentration on the label figure.
- Assumed: 10 mg in 2 mL, so 5.0 mg/mL.
- Actual: 7.8 mg in 2 mL, so 3.9 mg/mL.
- Every concentration downstream is high by 28%, and every molar figure derived from it inherits the same error.
Nothing in the experiment reports this. There is no error bar for a wrong starting assumption. It simply shifts the whole curve and looks like biology.
Two things close the gap. Ask whether the certificate reports net peptide content or an assay against a reference standard, not just area percent. And when it does not, compute the range you are actually working in rather than assuming the label. Volta's net peptide content calculator and salt form converter do the arithmetic above, and the molarity calculator will carry a corrected mass through to concentration.
What Each Analytical Method Can and Cannot See
"Tested" is not a method. The method determines which of the five questions the result is entitled to answer.
| Method | Answers | A pass means | It cannot see |
|---|---|---|---|
| RP-HPLC, area % | Purity | One species dominates the trace at the stated wavelength | Anything transparent at that wavelength, co-eluting species, or how much is in the vial |
| ESI-MS or MALDI-MS | Identity, partly | Observed mass matches the calculated mass | Residue order, D versus L stereochemistry, leucine versus isoleucine |
| MS/MS fragmentation | Identity, further | The fragment ladder constrains the sequence | Isobaric pairs on a low-resolution instrument, and anything with a blocked or cyclic terminus |
| Assay against a reference standard | Content | The vial holds the mass claimed | Which trace species are present |
| Water content determination | Content | How much of the powder is water | The peptide fraction on its own |
| Counterion analysis | Content | How much of the mass is salt | Anything about the peptide itself |
| Co-elution with a reference standard | Identity, properly | The material retains identically to a known sample of the compound | Nothing much, which is why it is the strongest and rarest test on this list |
The pattern is worth stating plainly. The identity question is the one most often assumed and least often tested. A matching molecular weight is consistent with the labelled sequence, and equally consistent with every rearrangement of the same residues, since mass is a sum and addition does not care about order. If identity matters to your work, the mass spec interpreter and the HPLC interpreter will tell you what a given report is and is not entitled to conclude.
The Canadian Layer
Everything above applies anywhere. Two things about it are specific to Canada.
The regulatory position is published, and it is not ambiguous
Health Canada's public advisory of 9 April 2026 states that "In Canada, peptides are generally regulated as prescription drugs." On the labelling convention this entire market rests on, it is equally direct: products are frequently sold with "research use only" or "not for human consumption" wording, and "this type of labelling does not make these products legal or exempt from regulatory requirements."
That is the regulator quoting itself, not an interpretation. Research-use framing describes an intended context. It is not a switch that removes a product from the Food and Drugs Act. The enforcement history, including the permanent injunction granted against Canlab Research by the Superior Court of Québec on 11 June 2026 and announced publicly on 29 July 2026, is covered in Peptides in Canada: From Insulin to the 2026 Research Landscape.
Domestic dispatch is a logistics fact, not a quality fact
A Canadian return address removes a border agency from the transaction. It removes seizure risk, brokerage fees and an unpredictable delay. It says nothing at all about what is in the vial, and a supplier that leads with domestic shipping instead of documentation has told you which of the two it would rather be judged on.
Two checks separate a Canadian company from a Canadian-looking one:
- The legal entity. A company name and a street address that resolve against a corporate registry, not a city name in a footer.
- The origin scan. The first carrier scan on a tracking number names the facility the parcel actually left. A .ca domain and CAD pricing are marketing decisions; the origin scan is not.
The step-by-step version of both checks, plus what happens to a parcel that does cross the border, is in Where to Buy Peptides in Canada Online.
A Ten-Minute Verification Pass
Run this before paying, in this order. It is ordered so that the cheapest disqualifying answer comes first.
- Ask for the certificate covering the lot currently shipping. Not a sample certificate, not last year's. The reply, and how long it takes, is itself a result.
- Match the identifiers. Compound name, labelled quantity, lot number and sample ID on the certificate should match what the product page and the vial say. Any mismatch stops the process here.
- Find the laboratory. A name, a report number, and a way to confirm the report from the laboratory's side rather than the vendor's.
- Read the method line. Column, gradient, wavelength. If the method is the single word "HPLC", you have a claim rather than a measurement.
- Look for the trace. A chromatogram and a peak table. A cover page carrying only a percentage has thrown away the evidence for the percentage.
- Separate purity from content. Find the assay, water and counterion figures, or note their absence and treat the label mass as an upper bound.
- Check the dates are chronological. Sample received, analysed, reported. Dates that run backwards, or a report older than the batch it supposedly describes, are worth a question.
- Ask one technical question by email. Something specific, such as which wavelength the area percent was integrated at. The quality of the reply is the cheapest and most discriminating test on this list.
- Write down what arrived. Date, condition, seal, lot, where it went. This takes thirty seconds and is what makes the result attributable six months later.
The COA-reading half of this pass is available as an interactive walkthrough in the COA explainer, and the failure patterns below are checkable against a document in the COA red flag checker.
Nine Failure Signatures
None of these proves a problem on its own. Each one changes what the document is entitled to claim.
| What you see | What it usually means | What to ask |
|---|---|---|
| One certificate used across every product | The report describes a batch you will never receive | "Which certificate covers the lot shipping today?" |
| No lot number anywhere | The chain has no first link | "What lot is on the vial, and where does it appear on the report?" |
| "Third-party tested" with no third party named | An unfalsifiable claim | "Which laboratory, and what is the report number?" |
| A purity figure with no method | A number without units | "What column, gradient and wavelength?" |
| A cropped screenshot instead of the report | The parts that were removed are the parts that would be checked | "Can I see the full report including the chromatogram?" |
| Purity reported, quantity absent | The more expensive question is unanswered | "Was net peptide content or assay measured?" |
| The certificate appears only after purchase | Documentation is being used as reassurance, not evidence | Ask before paying, every time |
| Names or quantities differ between pages of the report | Document assembly, not laboratory output | "Why does page 2 say something different from page 1?" |
| Body-outcome language on the product page | The vendor is not operating on a research-use footing | Nothing. This one is a decision rather than a question |
In Stock and Shipping from British Columbia
Every vial below ships domestically within Canada with a batch-specific Certificate of Analysis. Supplied for laboratory research use only.
Retatrutide 20mg
20mg
BPC-157 5mg
5mg
Retatrutide 10mg
10mg
GHK-Cu 50mg
50mg
Tesamorelin 10mg
10mg
BPC-157 10mg
10mg
Tirzepatide 10mg
10mg
KLOW 80mg
80mg
KPV 10mg
10mg
Ipamorelin 5mg
5mg
MOTS-C 10mg
10mg
TB-500 10mg
10mg
GHK-Cu 100mg
100mg
Tirzepatide 30mg
30mg
SS-31 10mg
10mg
5-Amino-1MQ 10mg
10mg
>99% HPLC purity standard. Read the Certificates of Analysis.
See the full Canadian catalogueWhere Volta Stands on This
Applying the same test to ourselves, plainly, including the part that currently reads worse than it will.
- Dispatch is domestic. Orders leave British Columbia and stay inside Canada. Volta Peptides Ltd publishes a legal entity and a Burnaby, BC business address, which is what makes the first check above possible to run against us.
- Every batch is tested by an independent laboratory, and the standard the catalogue is held to is >99% purity by HPLC.
- The public certificate archive is empty right now, and that is deliberate. The previous batch of certificates was retired and the replacements are not yet posted. Rather than leave superseded documents up, the archive says so and points at the address that will send the certificate covering your lot: team@voltapeptides.com. An archive that shows nothing is a worse look than one that shows something stale, and it is the more honest of the two.
- The research tooling is public and free, including the 48 calculators referenced throughout this article. A supplier that hands you the instruments to scrutinise its own material is making a different bet than one asking you to accept a badge.
For the compound-by-compound and price-by-price versions of this comparison, see the vendor comparison and what a vial actually costs in Canada.
Frequently Asked Questions
What does it mean to verify a peptide?
Confirming, from documents you can check, that the material in a specific vial is the compound named on the label, at the purity stated, in the quantity claimed, tested by a laboratory that can be identified. Four separate confirmations, not one.
Does a high HPLC purity result mean the vial is full?
No. Purity is the proportion of the detected signal attributable to the main component. Quantity is the mass of peptide present. A 99% pure vial can be materially short of its labelled amount, because water and counterion are part of the powder and not part of the purity figure.
Does a matching molecular weight confirm identity?
Not by itself. Mass is a sum of residue masses, and a sum does not encode order, so every rearrangement of the same residues returns the same number. A mass result is consistent with the labelled sequence rather than proof of it. Sequence-level confirmation needs fragmentation data or co-elution against a reference standard.
What is net peptide content?
The fraction of the lyophilised powder that is peptide rather than water, counterion or other residue. It is the figure that converts a label mass into an actual mass, and it is the most commonly missing field on a research-grade certificate.
Is a Canadian supplier automatically better?
No. Domestic dispatch removes border risk from the transaction and nothing else. Documentation quality and shipping origin are independent variables, and a supplier should be scored on both separately.
How current does a certificate need to be?
It needs to describe the lot being shipped, which is a stronger requirement than being recent. A three-month-old certificate for the correct lot is more useful than a certificate issued last week for a different one.
What should I record when an order arrives?
Arrival date, parcel condition, seal condition, the lot number from the vial, the storage location it went into, and the certificate filed alongside all of it. This is the only link in the chain the supplier cannot supply for you.
Where can I check a certificate against a checklist?
The COA explainer walks a report field by field, and the red flag checker tests a document against the failure signatures above. Both are free and require no account.
The Bottom Line
The Canadian peptide market is getting easier to evaluate, not because vendors have become more forthcoming, but because the questions being asked have got sharper. "Is it tested?" is being replaced by "tested for what, by whom, on which lot, at what wavelength."
That is the whole shift. A supplier's real quality signal is not the size of the number it prints. It is how much of the surrounding detail it is willing to publish alongside it, because detail is what makes a claim falsifiable, and a claim that cannot be falsified was never evidence to begin with.
Start with the lot number. Everything else in the chain hangs off it.
All materials referenced are supplied for laboratory and in-vitro research use only. Nothing in this article is medical advice, and no product discussed is offered for human or animal use.